Stock listing
OTC:HRGN Harvard Apparatus Regenerative Technology Inc Stock
Follow Harvard Apparatus Regenerative Technology Inc into a list and get an email when it puts out news.
Share price · OTC:HRGN
$1.90 USD 0.00 (0.0%)
Close on Nov 20, 2026
- Day range
- $1.90 – $1.90 USDNov 20, 2026
- Volume
- 1,200 sharesNov 20, 2026
- Market cap
- $38.54M USDAt the close on Nov 20, 2026 · price × 20.28M shares outstanding
- 52-week range
- $0.96 – $2.46 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $5,040 USDMedian day 950 shares · 12 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:HRGN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.90 | 0.00 | 0.0% | $1.90 | $1.90 | $1.90 | 1,200 | |
| $1.90 | 0.00 | 0.0% | $1.92 | $1.92 | $1.90 | 2,200 | |
| $1.90 | -0.08 | -4.0% | $1.90 | $1.90 | $1.90 | 10,100 | |
| $1.98 | +0.17 | +9.4% | $2.00 | $2.00 | $1.98 | 500 | |
| $1.81 | -0.28 | -13.4% | $2.01 | $2.01 | $1.81 | 4,920 | |
| $2.09 | +0.18 | +9.4% | $2.09 | $2.10 | $2.09 | 21,200 | |
| $1.91 | -0.39 | -17.0% | $2.25 | $2.25 | $1.91 | 2,344 | |
| $2.30 | 0.00 | 0.0% | $1.93 | $2.30 | $1.93 | 14,537 | |
| $2.30 | 0.00 | 0.0% | $2.45 | $2.45 | $2.30 | 700 | |
| $2.30 | +0.14 | +6.5% | $2.11 | $2.30 | $1.97 | 5,300 | |
| $2.16 | +0.20 | +10.2% | $1.97 | $2.16 | $1.97 | 2,100 | |
| $1.96 | 0.00 | 0.0% | $1.96 | $1.96 | $1.96 | 0 | |
| $1.96 | -0.002 | -0.1% | $1.954 | $1.96 | $1.954 | 900 | |
| $1.962 | 0.00 | 0.0% | $1.962 | $1.962 | $1.962 | 0 | |
| $1.962 | -0.008 | -0.4% | $1.962 | $1.962 | $1.962 | 100 | |
| $1.97 | -0.09 | -4.4% | $1.97 | $1.97 | $1.97 | 4,100 | |
| $2.06 | -0.14 | -6.4% | $2.06 | $2.06 | $2.06 | 200 | |
| $2.20 | -0.014 | -0.6% | $2.161 | $2.20 | $2.161 | 1,100 | |
| $2.214 | -0.016 | -0.7% | $2.23 | $2.23 | $2.214 | 700 | |
| $2.23 | -0.07 | -3.0% | $2.22 | $2.23 | $2.22 | 600 | |
| $2.30 | +0.05 | +2.2% | $2.30 | $2.30 | $2.30 | 800 | |
| $2.25 | +0.13 | +6.1% | $2.14 | $2.25 | $2.14 | 3,500 | |
| $2.12 | 0.00 | 0.0% | $2.12 | $2.12 | $2.12 | 0 | |
| $2.12 | -0.18 | -7.8% | $2.12 | $2.12 | $2.12 | 100 | |
| $2.30 | 0.00 | 0.0% | $2.30 | $2.30 | $2.30 | 100 | |
| $2.30 | 0.00 | 0.0% | $2.33 | $2.33 | $2.30 | 3,300 | |
| $2.30 | +0.05 | +2.2% | $2.25 | $2.30 | $2.25 | 2,100 | |
| $2.25 | +0.04 | +1.8% | $2.22 | $2.25 | $2.22 | 1,450 | |
| $2.21 | +0.02 | +0.9% | $2.25 | $2.25 | $2.21 | 1,406 | |
| $2.19 | -0.01 | -0.5% | $2.19 | $2.205 | $2.19 | 1,200 | |
| $2.20 | 0.00 | 0.0% | $2.20 | $2.20 | $2.20 | 0 | |
| $2.20 | +0.05 | +2.3% | $2.16 | $2.21 | $2.15 | 1,000 | |
| $2.15 | 0.00 | 0.0% | $2.15 | $2.15 | $2.15 | 0 | |
| $2.15 | +0.18 | +9.1% | $2.00 | $2.15 | $2.00 | 1,300 | |
| $1.97 | -0.003 | -0.2% | $2.00 | $2.00 | $1.97 | 7,100 | |
| $1.973 | -0.06 | -3.0% | $1.98 | $1.98 | $1.973 | 300 | |
| $2.033 | +0.223 | +12.3% | $2.033 | $2.033 | $2.033 | 400 | |
| $1.81 | -0.49 | -21.3% | $1.81 | $1.81 | $1.81 | 1,100 | |
| $2.30 | +0.05 | +2.2% | $2.20 | $2.30 | $2.20 | 1,600 | |
| $2.25 | -0.10 | -4.3% | $2.25 | $2.25 | $2.25 | 2,328 | |
| $2.35 | +0.05 | +2.2% | $2.35 | $2.35 | $2.35 | 1,617 | |
| $2.30 | 0.00 | 0.0% | $2.30 | $2.30 | $2.30 | 1,100 | |
| $2.30 | +0.34 | +17.3% | $2.00 | $2.30 | $2.00 | 5,600 | |
| $1.96 | 0.00 | 0.0% | $1.96 | $1.96 | $1.96 | 0 | |
| $1.96 | 0.00 | 0.0% | $1.96 | $1.96 | $1.96 | 0 | |
| $1.96 | -0.216 | -9.9% | $1.96 | $1.96 | $1.95 | 9,800 | |
| $2.176 | 0.00 | 0.0% | $2.176 | $2.176 | $2.176 | 0 | |
| $2.176 | -0.174 | -7.4% | $2.176 | $2.176 | $2.176 | 700 | |
| $2.35 | 0.00 | 0.0% | $2.35 | $2.35 | $2.35 | 0 | |
| $2.35 | +0.05 | +2.2% | $2.30 | $2.463 | $2.22 | 6,500 | |
| $2.30 | +0.78 | +51.3% | $1.58 | $2.40 | $1.58 | 12,500 | |
| $1.52 | -0.06 | -3.8% | $1.52 | $1.52 | $1.52 | 100 | |
| $1.58 | 0.00 | 0.0% | $1.58 | $1.58 | $1.58 | 0 | |
| $1.58 | -0.008 | -0.5% | $1.58 | $1.58 | $1.58 | 400 | |
| $1.588 | 0.00 | 0.0% | $1.588 | $1.588 | $1.588 | 26 | |
| $1.588 | +0.069 | +4.5% | $1.56 | $1.588 | $1.56 | 1,100 | |
| $1.519 | 0.00 | 0.0% | $1.519 | $1.519 | $1.519 | 0 | |
| $1.519 | 0.00 | 0.0% | $1.519 | $1.519 | $1.519 | 0 | |
| $1.519 | 0.00 | 0.0% | $1.519 | $1.519 | $1.519 | 50 | |
| $1.519 | +0.119 | +8.5% | $1.519 | $1.519 | $1.519 | 700 |
Splits
1 split · OTC:HRGN · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation |
- Ticker
- OTC:HRGN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Harvard Apparatus Regenerative Technology Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- Decks
- 2 decks · latest September 2023
Valuation
EV/sales 36.5× against a median of 26.0×: 7th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $36.69M USD
- P/E
- Loss
- EV/sales
- 36.5×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 73.8×
- Gross margin
- 7.5%
- Operating margin
- −643.0%
- Net margin
- −642.0%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.09
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Harvard Apparatus Regenerative Technology Inc · OTC:HRGN | US$38.54M | US$36.69M | n/a | 36.5× | n/a | 73.8× | −642.0% | 0.0× | 0.09 |
| Dogwood Therapeutics, Inc. · NASDAQ:DWTX | US$39.57M | US$34.74M | n/a | 347× | n/a | 0.6× | n/a | 0.0× | 0.79 |
| Herantis Pharma PLC · OMXHEX:HRTIS | US$38.69M | US$38.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Quratis Inc. · KRX:348080 | US$38.60M | US$29.66M | n/a | 36.2× | n/a | 1.1× | n/a | 0.0× | n/a |
| KoBioLabs, Inc. · KRX:348150 | US$38.47M | US$7.00M | n/a | 0.1× | n/a | 1.8× | −6.4% | 0.2× | n/a |
| OSE Immunotherapeutics SA · EURONEXT:OSE | US$38.31M | US$52.28M | n/a | 18.2× | n/a | 1.3× | n/a | 1.3× | n/a |
| Sprint Bioscience AB · OMXSTO:SPRINT | US$37.98M | US$28.86M | 5.1× | 2.1× | 3.7× | 4.3× | 54.4% | 0.0× | n/a |
| Theralase Technologies Inc. · TSXV:TLT | US$37.89M | US$34.22M | n/a | 61.1× | n/a | 7.9× | −472.5% | 0.0× | 0.75 |
| Connect Biopharma Holdings Limited · NASDAQ:CNTB | US$37.15M | US$18.16M | n/a | 4.9× | n/a | 3.1× | n/a | 0.0× | 0.93 |
| Coiled Therapeutics PLC · LSE:COIL | US$37.13M | US$30.46M | n/a | n/a | n/a | 0.6× | n/a | 0.0× | n/a |
| TaiRx, Inc. · TPEX:6580 | US$37.08M | US$28.62M | n/a | 33.8× | n/a | 3.3× | −793.3% | 0.0× | n/a |
| Median of the others | US$38.14M | US$30.06M | 5.1× | 26.0× | 3.7× | 1.8× | −239.4% | 0.0× | 0.79 |
Team and board
Officers
| Officer | Role |
|---|---|
| Jerry He | CEO |
| Joseph Damasio | Chief Financial Officer |
| Hong Yu | President |
| Shunfu Hu | VP of Business Development and Operations |
| William Fodor | Chief Scientific Officer |
Board
| Director | Role |
|---|---|
| Jerry He | CEO |
| David Green | Director |
| Herman Sanchez | Director |
| James Shmerling | Director |
| Jason Jing Chen | Vice Chairman |
| Mao Zhang | Director |
| Ron Packard | Director |
| Ting Li | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | May 18, 2026 | −6.7% |
| Q4 2025 | Feb 25, 2026 | +6.6% |
| Q3 2025 | Nov 28, 2025 | +8.8% |
| Q2 2025 | Aug 29, 2025 | −4.0% |
| Q1 2025 | May 12, 2025 · Before open | 0.0% |
| Q4 2024 | Mar 31, 2025 | 0.0% |
| Q3 2024 | Nov 11, 2024 · Before open | −2.0% |
| Q2 2024 | Aug 13, 2024 · Before open | 0.0% |
| Q1 2024 | May 13, 2024 · After close | 0.0% |
| Q4 2023 | Mar 28, 2024 · After close | +3.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2023 | Nov 13, 2023 · Before open | 0.0% |
| Q2 2023 | Aug 14, 2023 · Before open | 0.0% |
| Q1 2023 | May 12, 2023 · After close | +5.5% |
| Q4 2022 | Mar 30, 2023 · After close | +4.9% |
| Q3 2022 | Nov 14, 2022 | +1.8% |
| Q2 2022 | Aug 4, 2022 | −7.4% |
| Q1 2022 | Apr 1, 2022 | +10.0% |
| Quarter to Sep 30, 2021 | Nov 15, 2021 | +15.0% |
| Quarter to Jun 30, 2021 | Aug 13, 2021 | −13.8% |
| Quarter to Mar 31, 2021 | May 24, 2021 | 0.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2023) | Investor deck | 19 slides | September 2023 |
| Investor Presentation (September 2023) | Investor deck | 18 slides | September 2023 |
IPO
Withdrawn on May 2, 2013. Filed with the SEC to go public on Dec 11, 2012.
- Price range
- US$10.00 to US$12.00 a share
- Shares offered
- 1,700,000 shares of common stock
- Offering size
- US$17 million to US$20.4 million · Shares offered times the price range, worked out by 6ix
- Underwriters' option
- Up to 255,000 more shares
- Underwriters
- Summer Street Research Partners, Maxim Group LLC · In the order on the cover
Steps
| Step | When |
|---|---|
| Filed publicly | Dec 11, 2012 |
| Amended 5 times | Newest Mar 26, 2013 |
| Filing withdrawn | May 2, 2013 |
Filings
| Filing | Filed |
|---|---|
| CERTNAS · Nasdaq's certificate of listing | May 2, 2013 |
| RW · Request to withdraw a registration | May 2, 2013 |
| CERTNAS · Nasdaq's certificate of listing | Apr 9, 2013 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 1, 2013 |
| S-1/A · Registration statement, amended | Mar 26, 2013 |
| S-1/A · Registration statement, amended | Mar 20, 2013 |
| S-1/A · Registration statement, amended | Feb 28, 2013 |
| S-1/A · Registration statement, amended | Feb 15, 2013 |
| S-1/A · Registration statement, amended | Jan 18, 2013 |
| S-1 · Registration statement | Dec 11, 2012 |
Open IPO · From the cover of the amended prospectus (S-1/A) filed Mar 26, 2013
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 704.0K | 430.0K | 103.0K | 0 | 0 | 0 | 0 | 0 | 82.0K | |
| Cost of revenue | 646.0K | 270.0K | 24.0K | 0 | 116.0K | |||||
| Gross profit | 58.0K | 160.0K | 79.0K | 0 | -34.0K | |||||
| Research and development | 2.65M | 2.31M | 3.06M | 1.74M | 1.59M | 2.07M | 4.85M | 3.92M | 7.59M | 7.60M |
| Selling, general and administrative | 4.41M | 7.04M | 3.26M | 4.02M | 3.92M | 3.88M | 4.49M | |||
| Operating income | -6.92M | -7.73M | -8.99M | -6.15M | -8.64M | -5.33M | -8.87M | -7.84M | -11.5M | -12.1M |
| Depreciation and amortization | 5.00K | 14.0K | 35.0K | 52.0K | 107.0K | 184.0K | 214.0K | 261.0K | 413.0K | 454.0K |
| EBITDA | -6.91M | -7.71M | -8.96M | -6.10M | -8.53M | -5.14M | -8.66M | -7.58M | -11.1M | -11.7M |
| Interest expense | 8.00K | 38.0K | 14.0K | 9.00K | ||||||
| Income before tax | -6.87M | -7.73M | -11.9M | -11.6M | ||||||
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Net income | -6.87M | -7.73M | -8.95M | -6.07M | -7.98M | -4.87M | -8.33M | -7.53M | -11.9M | -11.6M |
| Earnings per share, basic | -0.42 | -0.52 | -0.67 | -0.55 | -0.79 | -0.55 | -1.21 | -1.69 | -6.63 | -14.49 |
| Earnings per share, diluted | -0.67 | -0.55 | -0.79 | -0.55 | -1.21 | -1.69 | -6.63 | -14.49 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.35M | 2.49M | 432.0K | 1.24M | 1.24M | 1.03M | 913.0K | 1.30M | 4.04M | 2.94M |
| Short-term investments | 1.20M | |||||||||
| Receivables | 16.0K | 231.0K | 4.00K | 0 | 42.0K | |||||
| Inventory | 16.0K | 80.0K | 50.0K | 0 | ||||||
| Current assets | 1.83M | 3.23M | 783.0K | 1.59M | 1.59M | 1.68M | 1.41M | 2.15M | 4.41M | 3.49M |
| Property, plant and equipment | 6.00K | 11.0K | 25.0K | 49.0K | 110.0K | 217.0K | 394.0K | 479.0K | 632.0K | 1.06M |
| Total assets | 2.68M | 4.44M | 2.61M | 2.40M | 1.87M | 2.08M | 1.99M | 2.63M | 5.04M | 4.55M |
| Accounts payable | 454.0K | 452.0K | 445.0K | 682.0K | 676.0K | 31.0K | 241.0K | 160.0K | 923.0K | 962.0K |
| Current liabilities | 1.53M | 1.02M | 968.0K | 1.36M | 4.84M | 756.0K | 814.0K | 662.0K | 1.62M | 2.78M |
| Total liabilities | 1.62M | 1.22M | 968.0K | 1.41M | 4.89M | 951.0K | 903.0K | 662.0K | 1.62M | 2.78M |
| Shareholders' equity | 1.06M | 3.22M | 1.65M | -3.19M | -3.03M | 1.13M | 1.09M | 1.97M | 3.42M | 1.77M |
| Shares outstanding | 17.6M | 15.9M | 13.9M | 12.2M | 10.8M | 9.39M | 8.16M | 5.67M | 2.51M | 855.4K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3.83M | -4.85M | -6.94M | -5.11M | -2.63M | -4.04M | -6.06M | -7.64M | -11.0M | -9.06M |
| Capital spending | 0 | -11.0K | -5.00K | 0 | -7.00K | -129.0K | -131.0K | -136.0K | -302.0K | |
| Free cash flow | -4.85M | -6.95M | -5.11M | -2.63M | -4.05M | -6.19M | -7.77M | -11.2M | -9.36M | |
| Cash from investing | 0 | -11.0K | -5.00K | 0 | -7.00K | -129.0K | -67.0K | -136.0K | -302.0K | |
| Cash from financing | 2.70M | 6.91M | 6.14M | 5.06M | 2.84M | 4.16M | 5.80M | 5.02M | 12.2M | 4.84M |
| Share buybacks | 0 | -42.0K | 0 | |||||||
| Change in cash | -1.13M | 2.05M | -809.0K | -51.0K | 216.0K | 113.0K | -392.0K | -2.68M | 1.10M | -4.51M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 13, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Sep 25, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 14, 2026 | Material contract | SEC |
| D | Sep 14, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 3, 2026 | Material contract | SEC |
| 8-K/A · Current report, amended | Aug 3, 2026 | Material contract | SEC |
| 8-K · Current report | Jun 23, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 13, 2026 | Quarterly report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Apr 28, 2026 | Current report | SEC |
| DEF 14A · Proxy statement | Apr 23, 2026 | Meeting notice | SEC |
| 8-K · Current report | Apr 15, 2026 | Current report | SEC |
| 10-K · Annual report | Mar 19, 2026 | Annual report | SEC |
| D | Jan 6, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 6, 2026 | Material contract | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 7, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 11, 2025 | Quarterly report | SEC |
| D | Jul 14, 2025 | Other filings | SEC |
| 8-K · Current report | Jul 14, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 24, 2025 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 14, 2025 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Apr 29, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 17, 2025 | Meeting notice | SEC |
| 8-K · Current report | Apr 14, 2025 | Current report | SEC |
| 10-K · Annual report | Mar 31, 2025 | Annual report | SEC |
| CORRESP · Letter to the SEC | Jan 6, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | Dec 12, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2024 | Material contract | SEC |
| 4 · Change in ownership | Sep 26, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 26, 2024 | Insider trade | SEC |
| SC 13D · Big-stake notice | Sep 26, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 12, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 27, 2024 | Management or board change | SEC |
| 8-K · Current report | Aug 21, 2024 | Material contract | SEC |
| SC 13D/A · Big-stake notice, amended | Aug 16, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 13, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 7, 2024 | Insider trade | SEC |
| D | Aug 6, 2024 | Other filings | SEC |
| 4 · Change in ownership | Jul 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 24, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 13, 2024 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Apr 29, 2024 | Meeting notice | SEC |
| 8-K · Current report | Apr 17, 2024 | Material contract | SEC |
| 10-K · Annual report | Mar 28, 2024 | Annual report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 6, 2024 | Material contract | SEC |
| 4 · Change in ownership | Jan 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 18, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2023 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Nov 16, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Sep 18, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 23, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2023 | Insider trade | SEC |
| 8-K · Current report | Jul 20, 2023 | Current report | SEC |
| 8-K · Current report | Jul 19, 2023 | Meeting outcome | SEC |
| 4/A · Change in ownership, amended | Jul 10, 2023 | Insider trade | SEC |
| 8-K/A · Current report, amended | Jul 10, 2023 | Management or board change | SEC |
| DEFR14A | Jun 7, 2023 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jun 7, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jun 5, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | May 2, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 2, 2023 | Insider trade | SEC |
| D | Apr 14, 2023 | Other filings | SEC |
| 4 · Change in ownership | Apr 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 10, 2023 | Insider trade | SEC |
| 8-K · Current report | Apr 10, 2023 | Management or board change | SEC |
| 8-K · Current report | Apr 6, 2023 | Material contract | SEC |
| 10-K · Annual report | Mar 30, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 14, 2023 | Management or board change | SEC |
| 8-K · Current report | Mar 7, 2023 | Material contract | SEC |
| 4 · Change in ownership | Mar 2, 2023 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 16, 2023 | Big-stake notice | SEC |
| RW · Request to withdraw a registration | Feb 1, 2023 | Other filings | SEC |
| 4 · Change in ownership | Jan 27, 2023 | Insider trade | SEC |
| 8-K · Current report | Jan 26, 2023 | Management or board change | SEC |
| 8-K · Current report | Jan 12, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Jan 5, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 28, 2022 | Current report | SEC |
| 8-K · Current report | Dec 23, 2022 | Current report | SEC |
| 4 · Change in ownership | Dec 9, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 9, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 9, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 8-K · Current report | Nov 14, 2022 | Results | SEC |
| S-1/A · Registration statement, amended | Oct 27, 2022 | Offer document | SEC |
| 8-K · Current report | Oct 12, 2022 | Current report | SEC |
| 8-K/A · Current report, amended | Sep 20, 2022 | Meeting outcome | SEC |
| 4 · Change in ownership | Aug 9, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 9, 2022 | Insider trade | SEC |
| 8-K · Current report | Aug 9, 2022 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 4, 2022 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2022 | Results | SEC |
| 8-K · Current report | Aug 2, 2022 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Jul 6, 2022 | Meeting notice | SEC |
| 4 · Change in ownership | Jul 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2022 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Jun 22, 2022 | Meeting notice | SEC |
| 8-K · Current report | Jun 22, 2022 | Meeting outcome | SEC |
| S-1 · Registration statement | Jun 21, 2022 | Offer document | SEC |
| SC 13G · Big-stake notice | Jun 21, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Jun 13, 2022 | Financing | SEC |
| D | Jun 8, 2022 | Other filings | SEC |
| 4 · Change in ownership | May 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | May 16, 2022 | Quarterly report | SEC |
| 8-K · Current report | May 16, 2022 | Results | SEC |
| 8-K · Current report | May 13, 2022 | Material contract | SEC |
| DEFA14A · Additional proxy material | May 2, 2022 | Meeting notice | SEC |
| DEF 14A · Proxy statement | May 2, 2022 | Meeting notice | SEC |
| 8-K · Current report | Apr 28, 2022 | Material contract | SEC |
| 8-K · Current report | Apr 1, 2022 | Results | SEC |
| 10-K · Annual report | Mar 31, 2022 | Annual report | SEC |
| 8-K · Current report | Feb 3, 2022 | Current report | SEC |
| 8-K · Current report | Jan 27, 2022 | Current report | SEC |
| 4 · Change in ownership | Jan 3, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2022 | Insider trade | SEC |
| 8-K · Current report | Dec 6, 2021 | Current report | SEC |
| 4 · Change in ownership | Nov 30, 2021 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 30, 2021 | Insider trade | SEC |
| 8-K · Current report | Nov 30, 2021 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 15, 2021 | Quarterly report | SEC |
| 8-K · Current report | Nov 15, 2021 | Results | SEC |
| 4 · Change in ownership | Nov 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2021 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 10, 2021 | Insider trade | SEC |
| 8-K · Current report | Sep 24, 2021 | Current report | SEC |
| SC 13G · Big-stake notice | Sep 23, 2021 | Big-stake notice | SEC |
| D/A | Sep 10, 2021 | Other filings | SEC |
| SC 13D/A · Big-stake notice, amended | Sep 9, 2021 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 9, 2021 | Insider trade | SEC |
| 8-K · Current report | Sep 8, 2021 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 13, 2021 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2021 | Results | SEC |
| 8-K · Current report | Jul 9, 2021 | Current report | SEC |
| 8-K · Current report | Jun 28, 2021 | Meeting outcome | SEC |
| 8-K · Current report | Jun 24, 2021 | Current report | SEC |
| D | Jun 23, 2021 | Other filings | SEC |
| SC 13D/A · Big-stake notice, amended | Jun 23, 2021 | Big-stake notice | SEC |
| 8-K · Current report | Jun 22, 2021 | Material contract | SEC |
| 4 · Change in ownership | Jun 21, 2021 | Insider trade | SEC |
| 8-K · Current report | May 27, 2021 | Current report | SEC |
| 10-Q · Quarterly report | May 24, 2021 | Quarterly report | SEC |
| 8-K · Current report | May 24, 2021 | Results | SEC |
| NT 10-Q · Late filing notice | May 17, 2021 | Explanation request | SEC |
| 3 · Initial statement of ownership | May 4, 2021 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Apr 30, 2021 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 30, 2021 | Meeting notice | SEC |
| 10-K · Annual report | Apr 13, 2021 | Annual report | SEC |
| 8-K · Current report | Apr 13, 2021 | Results | SEC |
| NT 10-K · Late filing notice | Mar 31, 2021 | Explanation request | SEC |
| 8-K · Current report | Feb 19, 2021 | Management or board change | SEC |
| 8-K · Current report | Feb 4, 2021 | Management or board change | SEC |
| 4 · Change in ownership | Feb 1, 2021 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 1, 2021 | Insider trade | SEC |
| 8-K · Current report | Jan 25, 2021 | Management or board change | SEC |
| 8-K · Current report | Dec 30, 2020 | Current report | SEC |
| 10-Q · Quarterly report | Nov 13, 2020 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2020 | Results | SEC |
| 3 · Initial statement of ownership | Nov 6, 2020 | Insider trade | SEC |
| 8-K · Current report | Oct 30, 2020 | Management or board change | SEC |
This page holds 200 of 626 filings. Open Filings
Cap table
Built by 6ix from Harvard Apparatus Regenerative Technology Inc’s releases
- Common shares
- 20,284,471
- Fully diluted
- 20,284,471
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 20,284,471 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 20,284,471 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jeffrey E Young Other companies: Juniper Pharmaceuticals Inc (Chief Financial Officer · Jan 1, 2017 – Aug 14, 2018 · Past); Tempest Therapeutics, Inc. (Chief Financial Officer · Sep 8, 2014 – Dec 3, 2015 · Past) | Director · Nov 6, 2018 – Jun 25, 2020 · Past |
| John J Canepa Other companies: Candel Therapeutics, Inc. (Chief Financial Officer · Jul 26, 2021 – Feb 28, 2022 · Past) | Director · Oct 16, 2013 – Mar 14, 2018 · Past |
| Ronald J Packard Other companies: Stride, Inc. (Chief Executive Officer, Director · Mar 28, 2013 – Dec 31, 2013 · Past) | Director · Since at least Apr 5, 2023 |
| David Green | Director · Since at least Nov 5, 2026 |
| Herman Sanchez | Director · Since at least Jan 19, 2021 |
| Hong Yu | President · Since at least Nov 5, 2026 |
| James Joseph McGorry | Chief Executive Officer, Director · Oct 16, 2013 – Jun 12, 2018 · Past |
| James Mastridge | See Remarks · Oct 29, 2020 – Oct 29, 2020 · Past |
| James Shmerling | Director · Since at least Jun 27, 2025 |
| Jason Jing Chen | Vice Chairman · Since at least Nov 5, 2026 |
All 23 people
| Person | Seat |
|---|---|
| Jerry He | CEO · Since at least Nov 4, 2026 |
| Jing Chen | Director · Since at least Feb 6, 2018 |
| Joseph Damasio | Chief Financial Officer · Since at least Nov 5, 2026 |
| Junli He | CEO, Director · Since at least Sep 1, 2021 |
| Mao Zhang | Director · Since at least Aug 26, 2024 |
| Peter A Pellegrino | Interim VP of Finance · Apr 8, 2021 – Apr 8, 2021 · Past |
| Peter M Chakoutis | Vice President of Finance · Aug 8, 2019 – May 14, 2020 · Past |
| Ron Packard | Director · Since at least Nov 4, 2026 |
| Saverio LaFrancesca | President and CMO, Director · Apr 29, 2015 – Aug 24, 2017 · Past |
| Shunfu Hu | VP of Business Development and Operations · Since at least Nov 5, 2026 |
| Thomas McNaughton | Chief Financial Officer · Jun 14, 2019 – Jun 14, 2019 · Past |
| Ting Li | Director · Since at least Nov 5, 2026 |
| William Fodor | Chief Scientific Officer · Since at least Mar 23, 2018 |
Log in to ask 6ix AI your own questions about Harvard Apparatus Regenerative Technology Inc.